Zakaria, S., Gad, G., Mahmoud, M., Elfarash, A., Elmokhtar, M., Mohamed, H. (2024). Resistance Profiles, Virulence Factors, Genotypes and Clinical Outcomes of Klebsiella Pneumonia Isolated from Patients with Community-Acquired Pneumonia. Afro-Egyptian Journal of Infectious and Endemic Diseases, 14(2), 154-172. doi: 10.21608/aeji.2024.267386.1355
Shimaa B Zakaria; Gamal F. M. Gad; Manal A Mahmoud; Ameer E Elfarash; Mohamed A. Elmokhtar; Heba A Mohamed. "Resistance Profiles, Virulence Factors, Genotypes and Clinical Outcomes of Klebsiella Pneumonia Isolated from Patients with Community-Acquired Pneumonia". Afro-Egyptian Journal of Infectious and Endemic Diseases, 14, 2, 2024, 154-172. doi: 10.21608/aeji.2024.267386.1355
Zakaria, S., Gad, G., Mahmoud, M., Elfarash, A., Elmokhtar, M., Mohamed, H. (2024). 'Resistance Profiles, Virulence Factors, Genotypes and Clinical Outcomes of Klebsiella Pneumonia Isolated from Patients with Community-Acquired Pneumonia', Afro-Egyptian Journal of Infectious and Endemic Diseases, 14(2), pp. 154-172. doi: 10.21608/aeji.2024.267386.1355
Zakaria, S., Gad, G., Mahmoud, M., Elfarash, A., Elmokhtar, M., Mohamed, H. Resistance Profiles, Virulence Factors, Genotypes and Clinical Outcomes of Klebsiella Pneumonia Isolated from Patients with Community-Acquired Pneumonia. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2024; 14(2): 154-172. doi: 10.21608/aeji.2024.267386.1355
Resistance Profiles, Virulence Factors, Genotypes and Clinical Outcomes of Klebsiella Pneumonia Isolated from Patients with Community-Acquired Pneumonia
1Department of microbiology and immunology, faculty of pharmacy, Minia university
2Department of Chest diseases and tuberculosis, faculty of medicine, Assiut university
3Department of Genetics, faculty of agriculture, Assiut university
4Department of microbiology and immunology, faculty of pharmacy, Assiut university
Abstract
Background and study aim: Klebsiella pneumonia, particularly the hypervirulent (hvKP) strains, are resistant to antibiotics and cause infections difficult to treat. This study aimed to compare clinical presentation, severity of infection, resistance profiles, virulence factors, genotypes and clinical outcomes of the classical (CKP) and the (HvKP) isolates in patients with Community acquired pneumonia (CAP). Patients and Methods: Ninety nine patients with CAP were enrolled in this study, sputum samples were taken, processed and cultured for isolation of K. pneumonia. Isolated K. pneumonia were identified by conventional methods and PCR. Hyperviruelnce was detected by string test and PCR. Virulence genes were detected using multiplex PCR and finally Genotyping was done using ERIC PCR. Results: A total of 99 K. pneumoniae isolates were recovered, 29 (29.3%) were identified as hvKP while 70 (70.7%) were cKP. Pneumonia caused by Hvkp isolates showed more intensive care unit admission, vasopressor use, and need for mechanical ventilation while mortality doesn't differ between Ckp and Hvkp isolates. Capsular serotypes K1, K2 and K5 were more prevalent in hvKP. However, capsular serotype K20 was more prevalent in cKP. Among all isolates, entB and ycfm (89.8% and 94.9%, respectively) were the most common virulence genes. rmpA, wcaG, uge and kfu were more predominant in hvKP isolates. Isolates were categorized into 12 ERIC types. Conclusion: Our findings support the effectiveness and applicability of the ERIC-PCR technique for molecular typing, epidemiological investigation of nosocomial infections, and analysis of genetic diversity among hospital pathogens, including K. pneumoniae strains. K. pneumoniae strains obtained from Egyptian hospitals displayed a considerable amount of variability in their antibiotic resistance and ERIC profiles.
Highlights
Klebsiella pneumonia, particularly the hypervirulent (hvKP) strains, are resistant to antibiotics and cause infections difficult to treat.
This study showed that pneumonia caused by Hvkp isolates showed more intensive care unit admission, vasopressor use, and need for mechanical ventilation while mortality doesn't differ between Ckp and Hvkp isolates.
Capsular serotypes K1, K2 and K5 were more prevalent in hvKP. However, capsular serotype K20 was more prevalent in cKP.
rmpA, wcaG, uge and kfu were the predominant vilrulence genes in hvKP
In Enterobacteriaceae family, Klebsiella pneumoniae is a significant opportunistic Gram-negative infection that primarily causes pneumonia [1]. Moreover, it plays a significant role in global nosocomial infections [2, 3]. A combination of phenotypic and genotypic characteristics distinguishes hypervirulent Klebsiella pneumoniae (hvKP) from classic Klebsiella pneumoniae (cKP). A string test on agar plates shows that hvKP bacteria overproduce a polysaccharide capsule, which causes their distinctive hypermucoviscosity. HvKP strains have this quality, which has previously been used to characterize the disease [4, 5]. Aerobactin, a siderophore that aids the bacterium in its battle with the host for iron and was used to discover hvKP [6], is one of the primary virulence factors in K. pneumoniae. PCR and the string test were used to determine whether strains of hvKp were aerobactin-positive and hypermucoviscous [7].
HvKP has caused serious invasive infections over the last two decades. As a clinically relevant pathogen, it differs from the cKP seen in both healthy and immunocompromised individuals [8]. In addition, unlike hvKP strains, the majority of cKP strains seldom exhibit common antimicrobial agent resistance, with the exception of ampicillin [9].
Variable virulence factor genes in K. pneumoniae play important roles in disease progression. One of the typical virulence factors is the capsule polysaccharide (K antigen) on its surface. There are at least 77 identified capsular serotypes, and each has a different range of sickness severity. The most virulent strains of the 77 capsular serotypes (K) have been identified, and mouse models have demonstrated this virulence in strains having capsular serotypes K1 and K2 [10].According to several researches, K1 and K2 capsular serotypes have a significant incidence of hvKP isolates [11].
A number of virulence genes, such as regulator of mucoid phenotype A (rmpA) and wcaG (encoding GDP-fucose synthetase), have been identified as contributing to the hypervirulent phenotype [12-14]. RmpA is a transcriptional activator of Capsular polysaccharide synthesis (CPS) gene transcription, CPS synthesis, and hypervirulence in K. pneumoniae K1/K2 [15].
Among the important virulence factors in K. pneumoniae is the kfu gene, which encodes for an iron uptake system and is strongly linked to purulent tissue infections and hypervirulence [10]. Furthermore, iron acquisition systems are encoded by the iutA, iroN, and entB genes, whereas lipopolysaccharides are encoded by the uge, wabG, ycfM, and allS genes [16]. These elements all have a role in virulence and are crucial for invasion, colonisation, and pathogenicity. Klebsiella spp. showed one of the most dramatic recent increases in multidrug-resistant (MDR) from 2001 to 2011 [17]. It is worth noting that patients with multidrug-resistant infections, such as K. pneumoniae, have a high mortality rate [18, 19]. Typically, these MDR infections are challenging to treat since there are so few antibiotics like tigecycline, colistin, Fosfomycin, and aminoglycosides available [20].
There is little information known about the clinical and microbiological aspects of community-acquired pneumonia (CAP) brought on by hvKP. This study compared the clinical presentation, resistance profiles, virulence factors, genotypes, and outcomes of the conventional and hypervirulent K. pneumoniae isolates in patients with community-acquired pneumonia (CAP) admitted to Assiut University hospitals due to the growing significance of hvKP and their impact on patients' morbidity and mortality.
PATIENTS/MATERIALS AND METHODS
For this prospective cohort research, 99 adult patients with CAP were hospitalized to the Chest Department at Assiut University Hospital in Egypt. CAP was described as the appearance of a new pulmonary infiltrate on chest radiography together with pneumonia-like symptoms such coughing, shortness of breath, a rise in body temperature, and/or chest discomfort that were not picked up in a hospital [21]. Patients who had non K. pneumoniae or mixed positive sputum cultures were excluded from the study. The study was carried out in compliance with the Declaration of Helsinki.
Acute Physiology and Chronic Health Evaluation score (APACHE II), Sequential Organ Failure Assessment score (SOFA), complete blood count, liver and kidney function tests, history, clinical examination, chest radiography, arterial blood gases (ABG) analysis, and bacteriologic examination of sputum samples were all obtained from each patient.For each enrolled patient a high-quality sputum (i.e. thick, purulent, at least 1ml volume, and showing < 10 squamous epithelial cells and > 25 leukocytes per optical microscopy field) were collected and processed for bacterial cultivation on culture media [22].
K. pneumoniae was identified by Gram-staining, mucoid pink colonies on MacConkey, lactose fermenting. The identification of Klebsiella pneumonia was further carried out using Vitek 2 system and confirmed using Polymerase Chain Reaction (PCR) [23].
2. Testing for hypervirulence
Aerobactin-positive and hypermucoviscous isolates were recognized as hvKp by PCR and a string test [24] . CKP and hvKP strains were distinguished using the string test. A viscous string longer than 5 mm is considered a positive string test when it is applied to a bacterial colony that has been stretched after being grown overnight on an agar plate at 37°C [25].
3. Antimicrobial susceptibility testing
The Kirby-Bauer technique was employed for assessing antibiotic susceptibility, in accordance with the Clinical and Laboratory Standards Institute (CLSI) on Antimicrobial Susceptibility Testing. Each K. pneumoniae isolate was grown in Mueller Hinton broth from Oxoid in the UK for a whole night at 37°C. Bacterial cultures were adjusted to 0.5 on the MacFarland nephelometer scale (1.5 108 CFU/ml), then streaked onto Mueller Hinton agar (Oxoid, UK). Antimicrobial susceptibility and resistance were determined using the Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Tests. Antibiotic discs were provided by Bioanalysis in Turkey [26] .
Multidrug-resistant (MDR) isolates were those with resistance to three or more antimicrobial classes, whereas extremely drug-resistant (XDR) isolates were alarmingly likely to be resistant to all, or nearly all, approved antimicrobials, making them epidemiologically significant in addition to their multiple antimicrobial resistances. The term "pan drug-resistant" (PDR) refers to bacteria that are resistant to all classes of antibiotics that can be used as empirical treatments as well as all commercially accessible antimicrobial groups. These organizations were created in accordance with a suggestion made by an international expert for temporary uniform definitions of acquired resistance [27].
4. Analysis of the virulence genes by Multiplex PCR
The existence of several types of virulence-associated genes was investigated in K. pneumonia strains using three distinct sets of multiplex PCR techniques. For group 1, the PCR conditions were as follows: a 15-minute initial activation at 95°C, followed by 35 cycles of 94°C for 30 seconds, 58°C for 90 seconds, and 72°C for 90 seconds, and then an extension at 72°C for 10 minutes [28]. The amplification of groups 2 and 3 was carried out under the following thermal cycling conditions: after five minutes of 95°C pre-denaturation, 30 cycles (Applied Bio systems, USA) [29]. 10 minutes of final elongation at 72°C following 1 minute at 94°C, 1 minute at 58°C, and 1 minute at 72°C. A 1.8% agarose gel was used for the electrophoresis analysis of PCR results. Table 1 includes a summary of the oligonucleotide primers utilized.
5. Genotyping by Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction(ERIC-PCR)
To ascertain the genotypes of our isolated isolates, virulence gene profiles and ERIC-PCR were coupled. The primers ERIC1 (5′-ATGTAAGCTCCTGGGATTCAC-3′) and ERIC2(5′-AAGTAAGTGACTGGGGTGAGCG-3′) were used for ERIC-PCR [30]. In a 25 L solution, 40ng of the template genomic DNA, 1 U of Taq DNA polymerase, 2.5 mM MgCl2, 1.0 mM of each primer, and 0.2 mM of each dNTP were added. Using an Applied Bio-systems Bio-Rad PTC-200 Thermal Cycler, the following amplification methods were carried out: a 5-minute initial denaturation at 94°C, 35 cycles of 1 minute at 94°C, 1 minute at 49°C, and 3 minutes at 72°C, and a 10-minute final extension at 72°C. 2.0% agarose gel electrophoresis was used to separate the products of the ERIC-PCR.
Data analysis:
The obtained PCR products were gel electrophoresed (described before), the agarose gel photos were scanned by the Gene Profiler 4.03 computer software program, that uses automatic lane and peak finding for detecting the presence of banding patterns, to calculate the bands molecular weight, and a binary data matrix recording the presence (1) or the absence (0) of bands was made.
Then, the software package MVSP (Multi-Variate Statistical Package) was used to draw the different dendrograms and to calculate the genetic similarities using the Dice coefficient of similarity of Nei and Li [31].
n11 - designates the number of common bands for the two compared samples,
n10 - cases where the bands were visible only in the first sample,
n01 – when bands were visible in the other sample only [32].
Statistical analysis
All statistical calculations were completed using MedCalc statististical software. The descriptive data were presented using the mean, standard division (SD), median, and percentage. Chi-square tests (and, when applicable, Fisher's exact tests) were used to compare categorical measurements between groups. Further statistical data were rapidly examined using independent sample testing. Probability (P) values < 0.05 were considered significant in statistics.
RESULTS
1. Clinical characteristics of the cohort
This study included 99 CAP patients with microbiologically confirmed Klebsiella pneumoniae, cKP and hvKP were detected in 70.7% and 29.3% of cases, respectively. SOFA score, APACHE II score and shock at diagnosis of CAP were significantly higher in hvKP pneumonia cases (p= 0.001, 0.002, and 0.001, respectively). Derangement in pH and SPO2, intensive care unit (ICU) admission, vasopressor use, and need for mechanical ventilation were significantly predominant in hvKP pneumonia cases (p=0.001, 0.042, 0.002, 0.001 and 0.009, respectively), as shown in Tables 2 and 3.
Non-survivor’s group had significantly higher mean age 72.07± 8.8 versus 53.9± 12.3, SOFA score 11.1± 1.9 versus 8.7± 1.8 and APACHE II score 19.3± 3.4 versus 14.8± 2.3 (p= 0.001 for all). Moreover, shock at diagnosis, altered mental status, tachypnea, and elevated serum urea were also higher in the non-survivor groups (p= 0.001, 0.007, 0.001 and 0.033, respectively). Distribution of the virulence associated genes among survivors and non survivors did not show significant differences except for the capsular gene (K20) which was significantly (p=0.041) higher in the survivor’s group (Table 4). Table 4 lists the characteristics of patients with hvKP and cKP infections.
2. Antimicrobial resistance
There was no discernible difference between the cKP strains and the hvKP strains in terms of their resistance to the tested antimicrobials. Amoxicillin, Amoxicillin-clavulanic acid, and piperacillin were all ineffective against all hvKP and cKP isolates (fig.1).Similarly, 20% (14/70) of the classical K. pneumoniae isolates were MDR. 55.7% (39/70) were XDR and 24.2% (17/70) were PDR. In addition, 17.2% (5/29) of the hvKP isolates were MDR, 55.1% (16/29) were XDR and 27.5% (8/29) were PDR.
3. HvKP and CKP isolates' molecular features and genes related to pathogenicity
3.1. Genetic comparison between hvKP and cKP isolates
Each K. pneumoniae isolate was examined for the presence of genes encoding the capsule K antigen. 40/70, or 56.1%, of the cKP isolates lacked the K1, K2, K5, K20, K54, or K57 capsular types. Ten of the isolates were all K1 capsular types and were all hvKP. K2 and hvKP also had a good connection (6 out of the 7 isolates that belonged to capsular serotype K2 were hvKP). Similarly, 5 isolates were K5 type and belonged to the cKP group. In the cKP group, the K20 serotype accounted for 32.3% (32/99) of isolates, making it the most common capsular type. Table 5 compares the prevalence of genes and capsular serotypes associated with virulence in hvKP and cKP isolates.
Generally, ycfm 94/99 (94.5%) and entB 89/99 (89.8%) were the most common detected virulence genes among isolated K pneumoniae isolates. Interestingly, the virulence genes rmpA, wcaG, uge and kfu were detected at a higher frequency in hvKP group compared to the cKP isolates (p values= less than 0.001 in all cases) (Table 5).
3.2. Genotyping of Klebsiella pneumoniae isolates by virulence markers.
Dendrograms generated based on the presence of the isolates with 21 additional virulence markers revealed that the isolates were divided into five different clusters, with clusters A and B having three identical strains based on virulence genes included (79,17), (34,19), (62,40), (42,37), (53,51), and (54,52) respectively. The cluster C contains two stains that have the same (39, 12), (Figure 2). The remaining 12 isolates all produced singletons.
3.3. Genotyping of Klebsiella pneumoniae isolates by ERIC-PCR
Sizes of the bands, which ranged from 200 bp to more than 1 kb, ranged from 3 to 13. The results of the software analysis and electrophoresis reveal that K. pneumoniae isolates exhibit a high degree of genetic diversity. Based on their ERIC-PCR patterns, the isolates were categorized into 12 ERIC-types. Isolates allocated to the same clusters in the dendrogram shared more than 95% of the bands with other isolates (Figure 3). A (n=10), B (n=6), five isolates in each type (C/D), four isolates in each type (E/F), three isolates in each type (G/H/J), and two isolates in each type (K/L) were all identified by ERIC. The remaining 52 isolates (n=52) were unrelated, had a 95% similarity, and were of the categories M1–M52. Three clusters (A–D) were identified by dendrogram analysis of the ERIC genotyping: cluster B comprised seven different ERIC-types (A, B, C, D, E, G, and H), while cluster C contained four different ERIC-types (F, J, K, and L). These isolates were quite similar to one another, indicating that they are part of a clonal lineage.
Table 1. Multiplex PCR primers
Target
Primer
Sequence (5′ to 3′)
Size (bp)
Ref.
Group 1
Capsular type K1
MagAF1
GGTGCTCTTTACATCATTGC
1283
[85]
MagAR1
GCAATGGCCATTTGCGTTAG
Capsular type K2
K2wzy-F1
GACCCGATATTCATACTTGACAGAG
641
[86]
K2wzy-R1
CCTGAAGTAAAATCGTAAATAGATGGC
Capsular type K5
K5wzxF360
TGGTAGTGATGCTCGCGA
280
[86]
K5wzxR639
CCTGAACCCACCCCAATC
Capsular type K54
wzxK54F
CATTAGCTCAGTGGTTGGCT
881
[11]
wzxK54R
GCTTGACAAACACCATAGCAG
Capsular type K57
wzyK57F
CTCAGGGCTAGAAGTGTCAT
1037
[11]
wzyK57R
CACTAACCCAGAAAGTCGAG
Capsular type K20
wzyK20F
CGGTGCTACAGTGCATCATT
741
[11]
wzyK20R
GTTATACGATGCTCAGTCGC
RmpA
RmpAF
ACGACTTTCAAGAGAAATGA
434
[87]
RmpAR
CATAGATGTCATAATCACAC
WcaG
WcaGF
GGTTGGKTCAGCAATCGTA
169
[88)
WcaGR
ACTATTCCGCCAACTTTTGC
Group 2
iutA
iutA-F
GGCTGGACATCATGGGAACTGG
300
[89]
iutA-R
CGTCGGGAACGGGTAGAATCG
uge
uge-F
TCTTCACGCCTTCCTTCACT
534
[24]
uge-R
GATCATCCGGTCTCCCTGTA
allS
allS-F
CCGAAACATTACGCACCTTT
508
[24]
allS-R
ATCACGAAGAGCCAGGTCAC
fimH
fimH-F
TGCTGCTGGGCTGGTCGATG
688
[24]
fimH-R
’GGGAGGGTGACGGTGACATC
VatD
VatD-F
GAAGGAAACAAATCAGTA
463
[29]
VatD-R
GTTTTATTTCGTTAGCAG
Group 3
wabG
wabG-F
ACCATCGGCCATTTGATAGA
683
[90]
wabG-R
CGGACTGGCAGATCCATATC
ycfM
ycf-F
ATCAGCAGTCGGGTCAGC
160
[91]
ycf-R
CTTCTCCAGCATTCAGCG
entB
entB-F
ATTTCCTCAACTTCTGGGGC
371
[91]
entB-R
AGCATCGGTGGCGGTGGTCA
Aerobactin
AerobactinF
GCATAGGCGGATACGAACAT
556
[92]
AerobactinR
CACAGGGCAATTGCTTACCT
IroNB
iroNB-F
GGCTACTGATACTTGACTATTC
992
[93]
iroNB-R
CAGGATACAATAGCCCATAG
YbtS
YbtS-F
CACCGCAAACGCAATCTG
782
[29]
YbtS-R
GCCATAGACGCTGTTGTTGA
irp-2
irp-2-F
TCCCTCAATAAAGCCCACGCT
287
[94]
irp-2-R
TCGTCGGGCAGCGTTTCTTCT
Table 2. Characteristics of CAP patients in relation to classical and hypervirulent K. pneumonia.
Demographic data and health status
Variable
Ckp (n=70)
Hvkp (n=29)
DF
P value
Age
58.9±15.03
58.1±12.04
97
0.799
Gender
Male
35(50%)
16(55%)
1
0.804
Female
35 (50%)
13(44%)
DM
19(27%)
11(37%)
1
0.455
HTN
26(37%)
19(65%)
1
0.020*
IHD
1(1.4%)
2(6%)
1
0.549
Hepatic disesses
1(1.4%)LC/1(1.4%)HPS
0(0%)
-
SOFA score
8.9± 2.1
10.6±1.7
97
0.001*
APACHE II score
15.4±3.14
17.7±3.7
97
0.002*
Initial appropriate antibiotics
R
54 (70%)
23 (79%)
1
0.505
S
5 (7%)
2 (6 %)
1
0.795
Shock at diagnosis
18(25%)
23(79%)
1
0.001*
Laboratory investigations
WBCs (103/ul)
9.1 ±3.1
10.6 ± 5.2
1
0.079
Hb (gm/dl)
12.7± 2.4
11.5 ± 2.4
97
0.026*
Creatinine (umol/l)
72.5 ± 32.4
70.2 ± 36.1
97
0.757
Urea (mmol/l)
6.3± 5.7
7.7 ± 5.1
97
0.255
AST (U/L)
51.9± 33.6
51.5± 17.3
97
0.952
ALT (U/L)
44.8± 20.4
45.8± 18.8
97
0.821
Albumin (g/dl)
3.2± 3.7
2.8± 0.9
97
0.568
Na (mmol/l)
136± 7.5
139.2 ± 9
97
0.072
K (mmol/l)
3.9± 0.8
4.1 ± 0.6
97
0.229
PH
7.40± 0.04
7.30 ± 0.04
97
0.001*
PaO2 (mmHg)
56.7± 7.3
54.7 ± 7.7
97
0.225
PaCO2 (mmHg)
49.3± 12.9
44.6 ± 8.1
97
0.073
SPO2 (%)
90±2.05
83±3.47
97
0.042*
Table 3. Clinical outcomes of patients with pneumonia caused by K. pneumonia.
P value
DF
Hvkp (n= 29)
Ckp (n= 70)
Variable
0.825
97
9.5 ± 4.02
9.3 ± 4.1
Length of hospital stay (mean±SD)
0.002*
1
25(86%)
35(50%)
ICU Admission (No,%)
<0.001*
1
23(79%)
17(24%)
Vasopressor use (No,%)
0.009*
1
22(79%)
34(48%)
Mechanical ventilation (No, %)
0.944
1
3(10%)
6(8%)
Early mortality (≤48 h) (No, %)
0.947
1
6(20%)
12(17%)
In-hospital mortality (No, %)
* Statistically significant difference (p<0.05), DF (is the degree of freedom).
Table 4. Variables associated with in hospital mortality in CAP patients
Demographic data and health status (No, %)
Variable
Survivors (n=72)
Non survivors (n=27)
DF
P value
Age (mean±SD)
53.9±12.3
72.07 ±8.8
97
0.001*
Male (No,%)
38(52.7%)
13(48%)
1
0.849
Female (No,%)
34(47.2%)
14(51%)
1
0.912
SOFA score (mean±SD)
8.7±1.8
11.1±1.9
97
0.001*
APACHE II score (mean±SD)
14.8±2.3
19.3±3.4
97
0.001*
Shock at diagnosis
7 (9.7%)
11 (40.7%)
1
0.001*
Altered mental status
14 (19.4%)
21 (77.7%)
1
0.007*
Respiratory rate ≥ 30 breath/min
15 (20.8%)
19 (70.3%)
1
0.001*
Arterial PH ˂ 7.35
12 (16%)
17 (62.3%)
1
0.010*
Serum urea ˃ 10 mmol/L
20 (27.7%)
18 (66.6%)
1
0.033*
Virulence genes (No, %)
k54
2(2%)
1(3%)
1
0.646
k57
2(2%)
0(0%)
1
-
RmpA
23(31%)
10(37%)
1
0.744
WcaG
34(47%)
17(62%)
1
0.270
FimH
19(26%)
6(22%)
1
0.882
Uge
48(66%)
15(55%)
1
0.438
IutA
44(61%)
15(55%)
1
0.755
Kfu
6(8%)
4(14%)
1
0.604
VatD
21(29%)
5(18%)
1
0.393
WabG
46(63%)
17(62%)
1
0.887
AllS
13(18%)
7(25%)
1
0.621
Ycfm
67(93%)
25(92%)
1
0.792
IroN
6(8%)
5(18%)
1
0.286
YbtS
25(34%)
9(33%)
1
0.885
Aerobactin
20(27%)
9(33%)
1
0.735
IrpS
54(75%)
17(62%)
1
0.305
EntB
65(90%)
25(92%)
1
0.934
Multidrug resistance strain (No,%)
7 ( 5 – 10 )
7 ( 5 – 11)
97
0.975
Extensive drug resistance strain (No,%)
16(22%)
3(11%)
1
0.340
Pan drug resistance strain (No,%)
38(52%)
17(62%)
1
0.507
Multidrug resistance strain (No,%)
18(25%)
7(25.9%)
1
0.794
* Statistically significant difference (p<0.05), APACHE, Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment, DF (is the degree of freedom)
Table 5. Virulence genes in relation to hypervirulent and classical Klebsiella pneumoniae isolates.
Virulence related genes
hvKP (N= 29)
cKP (N= 70)
DF
P value
K1
10(34.4%)
0(0%)
1
-
K2
6(20.6%)
1(1.4%)
1
0.003*
K5
4(17.2%)
0(0%)
1
-
K20
5(13.7%)
27(38.5%)
1
0.029*
K54
2(6.8%)
1(1.4%)
1
0.430
K57
2(6.8%)
1(1.4%)
1
0.430
rmpA
29(100%)
5(7.1%)
1
<0.001*
wcaG
25(86.2%)
32(45.7%)
1
<0.001*
fimH
11(37.9%)
16(22.8%)
1
0.198
Uge
27(93.1%)
38(54.2%)
1
<0.001*
iutA
22(75.8%)
37(52.8%)
1
0.058
Kfu
8(27.5%)
1(1.4%)
1
<0.001*
vatD
6(20.6%)
21(30%)
1
0.479
WabG
21(72.4%)
43(61.4%)
1
0.418
AllS
7(24.1%)
12(17.1%)
1
0.599
Ycfm
29(100%)
65(92.8%)
1
0.327
IroN
10(34.4%)
0(0%)
1
-
YbtS
10(34.4%)
27(38.5%)
1
0.876
Aerobactin
29(100%)
0(0%)
1
-
IrpS
23(79.3%)
48(68.5%)
1
0.400
EntB
29(100%)
60(85.7%)
1
0.075
Chi-square test, * Statistically significant difference (p<0.05), DF (is the degree of freedom).
DISCUSSION
Bacterial strains and HV strains of K. pneumoniae.
A significant pathogen in both hospitals and the general population, K. pneumoniae is a Gram-negative, conditionally pathogenic bacillus. The lungs are the most frequently affected area of the human body, but it can affect numerous other areas as well.
Community-acquired pneumonia (CAP) caused by hvKP is uncommon, and there is little information available about its clinical and microbiological characteristics. The purpose of this study was to evaluate and compare the resistance profiles, virulence factors, and genotypes of classic and hypervirulent Klebsiella pneumoniae strains isolated from community acquired pneumonia (CAP) patients admitted to Assiut University Hospital's Chest Department. The clinical presentation and outcome of the patients who were enrolled were also evaluated. In Okinawa, Japan, Jun Hirai et al 2020 reported the first case of CAP caused by the capsular genotype K2-ST86 HV-KP[33].
According to the current findings, 70.7% of the isolates were cKP and 29.3% were hvKP. According to Jeong-Hwan Hwang et al., 2020, the majority of his isolates were Ckp (54% for Ckp versus 45.9% for hVkp) [34]. Yamamoto Hiroyuki, 2020 discovered an APACHE II score of 20 and septic shock at hvkp pneumonia diagnosis in his study [35], which was consistent with the current results, Chih-Han Juan et al 2020 reported a median APACHE II score of 23 and 29.4% of cases had septic shock [36]. Jeong-Hwan Hwang et al, 2020 found no difference in Shock at Diagnosis between Ckp and Hvkp pneumonia (p=0.474) [34]. Pneumonia caused by hypervirulent strains resulted in an increased need for mechanical ventilation (75.8%) and vasopressor use (79.3%), which was consistent with previous findings. According to [34, 36], hypervirulence determinants do not have a significant impact on mortality, but shock at diagnosis, altered mental status, respiratory rate 30 breath/min, arterial PH 7.35, serum urea 10 mmol/L were all significantly higher in hvkp pneumonia.
There is no denying that the internet has changed the way people communicate. I n the past, a positive string test has been used to define hypermucoviscosity, but more recent studies have shown that the two phenotypes are separate from one another [37]. Studies are finding more and more clinical isolates of K. pneumoniae that cause pyogenic liver abscesses without the typical hypermucoviscous appearance [38-40]. These findings suggested that hypermucoviscosity is not necessary for the hypervirulent phenotype of K. pneumoniae. Thus, employing hypermucoviscosity to define hvKP might not be accurate. A major virulence factor in human hvKP infection and survival is the siderophore aerobactin [6]. It is located on the large virulence phenotype of K. pneumoniae plasmid (pLVPK), which is present in the great majority of hvKP isolates but absent in cKP strains, and is assumed to represent a genetic factor for both hypermucoviscous and hypervirulent phenotypes [37, 41]. Because of its importance in the disease, aerobactin positivity was thought to be a defining genetic trait for hvKP [13]. Aerobactin was more sensitive but less specific than traditional hypermucoviscosity designation criteria for defining hvKP, which was consistent with previous research findings [13, 14].
The rmpA gene, which is found on the large virulence plasmid pLVPK and is known to enhance capsular formation [42], has previously been shown to be a significant virulence-associated component in hvKP isolates [13, 14, 43]. A high correlation between rmpA and hypervirulence was identified in our investigation, where the rmpA gene was found in 100% (29/29) of hvKP isolates but only in 5 of 70 cKP isolates. Also, it was looked at how rmpA affected the pathogenicity of cKP isolates that were rmpA positive.
The majority of hvKP bloodstream infections are acquired in the community, in contrast to traditional K. pneumoniae bloodstream infections, suggesting that hvKP isolates are crucial in the development of community-acquired [44]. Despite being a well-known common pathogen, K. pneumoniae has been associated with blood and urinary tract infections, community and hospital-acquired pneumonia, and all of these other illnesses [45]. Our results suggested a connection between hvKP and respiratory illnesses. This shows that respiratory infections are the primary cause of cKP strains. These numbers are consistent with earlier findings [4, 46]. The study is compatable with [47], in that hvKP is not correlated with either gender or age. Yet, other research revealed that hvKP patients were younger and more likely to be infected than female patients [44].
Antimicrobial resistance
The excessive use of antimicrobials get to high incidence of resistance in K. pneumonia [48]. All of the samples included in our investigation were made up of K. pneumoniae isolates that were multidrug resistant. Other studies [30, 49] discovered rates of more than 66.7% of MDR K. pneumoniae isolates. High rates of antimicrobial resistance were discovered in our study, and this can be related to Egypt's lax antibiotic use regulations [3]. MDR was found in 20% (14/70) of classical K. pneumoniae isolates, XDR in 55.7% (39/70), and PDR in 24.2% (17/70). In contrast, 17.2% (5/29) of hypervirulent K. pneumoniae isolates tested positive for MDR, 55.1% (16/70) tested positive for XDR, and 27.5% (8/29) tested positive for PDR. In [26], 84.37% (27/32) of K. pneumoniae isolates were MDR, 12.5% (4/32) were XDR, and 12% (1/32) were PDR. In contrast, 84.37% (27/32) of K. pneumoniae isolates were MDR.
The rate of K. pneumoniae resistance to fluoroquinolones varies according to the geographical distribution, e.g., resistance rates are 71.4% in Iran, 93.1% in Egypt, and 89% in India [50].
In this work, we compared the features of cKP and hvKP isolates' antibiotic resistance. Recent research has discovered that these strains are not only less related with antibiotic resistance but also less resistant to antibiotics than hvKP strains, which have previously been proven to be more resistant to antibiotics than cKP strains [4]. As a result, these data are inconclusive. In the current study, antibiotic resistance between hvKP strains and cKP strains was not significantly different.
Molecular characteristics and virulence-associated genes of hvKP and cKP isolates
In a model of rat subcutaneous abscess, the genetic features of virulence for hvKP and cKP showed that hvKP was more virulent than cKP [51) Six serotypes (K1, K2, K5, K20, K54, and K57) known to be extremely virulent and linked to serious infections in humans were examined in this work [52). K. pneumoniae serotypes K1 and K2 cause pyogenic liver abscess and have been linked to community-acquired pneumonia [53). K. pneumoniae has been classified into more than 70 capsular serotypes [54). Hypermucoviscous, or HV, strains are those with the K1 and K2 capsular serotypes that predominantly cause liver abscess and correspond to certain clones [55,56 ,57, 58]. Mucoviscosity-associated gene, or MagA The genes k1A (unique to K1 capsule serotype) and k2A play significant roles in the pathogenesis of liver abscess (specific to K2 capsule serotype) [59]. Several HV serotypes, including as K5, K20, K54, and K57, have been discovered in addition to K1 and K2 [25]. Our findings suggest that additional serotypes besides K1/K2/K5/K20/K54/K57 may play a significant role in hvKP infections. K20 was the most frequent capsular type in our study, however it was almost exclusively recovered from cKP isolates. This outcome is consistent with past studies where the K20 was more commonly found in strains other than hvKP [4, 60, 61]. As a consequence, it seems that the K20 capsule plays a less significant role in the pathogenesis of hypervirulent K. pneumoniae than was previously thought [11]. K1, K2 capsular genes are typically identified in hvKP strains and may also be present in cKP strains [10]; hvKP strains may also contain non-K1/K2 genes [57].
According to the findings, K1 and K2 were the most common capsule serotypes among hvKP isolates (34./*4%, 10/29), (20.6%, 6/29), which is consistent with previous research [44, 62].
In virulent strains of K. pneumonia, the capsular serotypes K1 and K2 predominate [30]. According to Feizabadi et al., 11.2% of all K. pneumoniae isolates were K2 serotypes [63].
A high viscosity phenotype was connected to the rmpA gene, a plasmid gene that controlled extracellular polysaccharide production [64-66]. In this investigation, the proportion of hypervirulent isolates containing the rmpA gene was 100%, which is much higher than in other findings from Beijing, China [13,44]. The findings support the hypothesis that rmpA-positive HV phenotypes are more resistant to phagocytosis by neutrophils and macrophages (65). It was determined that the capsular antigens (K1 and K2) and rmpA had a significant relationship to hvKP strains (P = 0.001 and P = 0.003, respectively). These findings support previous research that identified rmpA (P =.025) and the capsular antigens (K1 and K2) (P =.024 and.039, respectively) [4].
WabG, uge, and ycfM, genes related with capsules, enhance resistance to phagocytosis [67] . K. pneumoniae isolates frequently included these genes, which seem to be the cause of the pathogenicity of K. pneumoniae. The virulence gene areas discovered in this research were uge 65.6% (65/99), wabG 64.6% (64/99), and ycfm 94.8% (94/99), each of which encodes a component of the capsule, a lipoprotein component of the capsule, and an exterior membrane protein. These rates are in line with earlier studies showing that clinical strains of K. pneumoniae develop virulence factors [68].
Cammarota et al. (2003) [26,69] demonstrated that K. pneumoniae strains with a mutant wab G gene are non-capsulated and less virulent. This demonstrates how crucial the wab G gene is for the pathogenicity of K. pneumoniae. By demonstrating that mutant strains of K. pneumoniae (without the uge gene) were not virulent in laboratory animals, Regué et al. (2004) demonstrated the importance of the uge gene in K. pneumoniae pathogenicity [70,71].
Type 1 fimbriae and fimbrial adhesins are expressed in clinical strains of K. pneumoniae. Whereas type 1 fimbriae, which encode fimH, are crucial for the urinary tract infections (UTIs) caused by these strains [59]. Moreover, the siderophores encoding the iron-binding proteins entB, iutA, and iroN promote the development of biofilms [68, 72]. Fimbrial adhesins H (fimH) were found in 27% (27/99) of the samples, while siderophores (iutA, entB) were found in 59.5% (59/99) and 89.8% (89/99), respectively. Several microorganisms, including fungi and bacteria, create and release siderophores, which are bio-synthetic molecules that are selective chelators and synthesized for the uptake of iron (Fe+3). These ions are only slightly soluble and are present in practically all oxygenated situations. In this study, the irp-2 gene was found in 71.7% (71/99) of our isolates. These findings were consistent with previous research that found these chelators in almost all K. pneumoniae clinical isolates [68,73].
Bacteria create the siderophore substances enterobactin (entB) and yersiniabactin (ybtS) to absorb iron (Fe+3) from host iron-binding proteins. They contribute significantly to bacterial pathogenesis and virulence as high-affinity extracellular ferric chelators. Furthermore, enterobactin expression promoted biofilm formation [72]. During bacterial infection, the expression of iron-enterobactin appears to be activated [68].
It has been shown in mice that the kfu, which facilitates ferric iron absorption, is a virulence factor (10), and that hvKP strains tend to have more of it than cKP strains. The kfu gene, which codes for an iron absorption pathway, is thought to be pathogenic. The kfu gene is linked to purulent tissue infections, capsule formation, and virulent hypermucoviscosity. Thus, it is believed that this gene is crucial for the host cell's absorption of iron [74].
In comparison to cKP strains, hvKP strains produced more aerobactin [75,6]. Kim et al. determined that kfu and aerobactin are necessary for bacterial pathogenicity. The intake of iron is related to their protein products [76]. It is consistent with earlier studies [24,44] that Kfu and aerobactin were present in 100% (29/29) and 27.5% (8/29) of the hvKP isolates in this study, respectively. The discovery of wcaG-positive strains in patients with severe and invasive illnesses raises the possibility that wcaG may be involved in the emergence of these strains. Fucose, a component of the polysaccharide capsule of K. pneumoniae, has been linked to bacterial pathogenicity in mice, and it is produced in part by the wcaG protein [77]. This study's conclusion that the wcaG gene is extremely relevant for hvKP is in line with earlier studies [44].
Furthermore, a study found a strong correlation between the kfuB, allS gene, K1 serotype, and hvKP isolates [78]. There was no clear link between hyperviulence and the allS gene in this study. In comparison to cKP strains, hvKP strains have a higher prevalence of virulence-related genes, including K1, K2, rmpA, aerobactin, iutA, wcaG, iorN, irpS, uge, and kfu. The genes for FIM-1, ycfM, ybtS, wabS, and vatD did not significantly change between the two.
Genotyping of Klebsiella pneumoniae isolates by ERIC analyses
E. coli and, more recently, K. pneumoniae, members of the Enterobacteriaceae family, have both been detected using ERIC-PCR [79, 80]. The current investigation discovered a significant degree of genetic variability among various K. pneumoniae strains. In Ramazanzadeh et al (2013).'s investigation on the genetic diversity in clinical isolates of E. coli taken from hospitals in significant cities in western Iran, ERIC-PCR permitted typing of the 230 isolates into 205 ERIC types, which were further clustered into twenty (C01-C20) as principal clusters. Seifi et al. discovered that K. pneumoniae strains in a Tehran hospital had a high level of genetic diversity [79, 80]. In a hospital in Borujerd, Mehr et al. (2017) found that K. pneumoniae strains had a significant degree of genetic diversity [81-83]. In a hospital in Borujerd, Mehr et al. (2017) found that K. pneumoniae strains had a significant degree of genetic diversity [84]. 99 isolates from this investigation were discovered to exhibit 63 distinct ERIC profiles. As a result, 52 K. pneumoniae isolates generated separate profiles and were not grouped. Indeed, the non-clonal distribution of the bacterium in the hospitals under inquiry is reflected in the genetic diversity of K. pneumoniae strains.
CONCLUSION
Our research revealed no clinically meaningful differences in mortality amongst hvKP strains. Further studies are necessary to clarify the relationship between each distinct virulence factor and antibiotic resistance, as well as their influence on the clinical consequences of CAP caused by K. pneumoniae. Strict infection control measures must be put in place, together with good monitoring, to stop the spread of multidrug resistant hvKP. Our findings support the effectiveness and applicability of the ERIC-PCR technique for molecular typing, epidemiological investigation of nosocomial infections, and analysis of genetic diversity among hospital pathogens, including K. pneumoniae strains. K. pneumoniae strains obtained from Egyptian hospitals displayed a considerable amount of variability in their antibiotic resistance and ERIC profiles. Hospital infections caused by K. pneumoniae strains are difficult to cure when this variation is present.
Funding: researchers in this study did not receive funding from any institution.
Conflict of Interest: The authors declare no conflict of interest.
Ethical approval The study was carried out in compliance with the Declaration of Helsinki and authorised by the Faculty of Medicine Ethics Committee, Assiut University's Institutional Review Board" (ID: 17101223).
Author contributions: Each author made a contribution to the project's planning, patient research, sample collection, data processing, or data interpretation. Each contributor contributed to the drafting and editing of the manuscript.
Abbreviations: HvKP: hypervirulent Klebsiella pneumonia, CKP: classic Klebsiella pneumoniae, CPS: Capsular polysaccharide synthesis, MDR: multidrug-resistant,CAP: community-acquired, APACHE II: pneumonia Acute Physiology and Chronic Health Evaluation score, SOFA: Sequential Organ Failure Assessment score, ABG: arterial blood gases, PCR: Polymerase Chain Reaction, CLSI: Clinical and Laboratory Standards Institute , MDR: Multidrug-resistant , XDR: extremely drug-resistant, PDR: pan drug-resistant, ERIC-PCR: Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction, MVSP: Multi-Variate Statistical Package, SD: standard division, P: Probability, ICU: intensive care unit, pLVPK: phenotype of K. pneumoniae plasmid, UTIs: urinary tract infections.
References
Gorrie CL, Mirčeta M, Wick RR, Judd LM, Lam M, Gomi R, et al. Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen. Nat Commun 2022; 13(1):1-17.
2. Abdel-Wahab F, Ghoneim M, Khashaba M, El-Gilany AH, Abdel-Hady D. Nosocomial infection surveillance in an Egyptian neonatal intensive care unit. J Hosp Infect 2013; 83(3):196-9.
3. Daef EA, Elsherbiny NM. Clinical and microbiological profile of nosocomial infections in adult intensive care units at Assiut University hospitals, Egypt. J Amer Sci 2012; 8(12):1239-50.
4. Li W, Sun G, Yu Y, Li N, Chen M, Jin R, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin infect dis 2014; 58(2):225-32.
5. Zhan L, Wang S, Guo Y, Jin Y, Duan J, Hao Z, et al. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 isolates with carbapenem resistance in a tertiary hospital in China. Front Cell Infect Microbiol 2017; 7:182.
6. Russo TA, Olson R, MacDonald U, Metzger D, Maltese LM, Drake EJ, et al. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immunol 2014; 82(6):2356-67.
7. Wu Y, Wang R, Xu M, Liu Y, Zhu X, Qiu J, et al. A Novel Polysaccharide Depolymerase Encoded by the Phage SH-KP152226 Confers Specific Activity Against Multidrug-Resistant Klebsiella pneumoniae via Biofilm Degradation. Front Microbiol. 2019; 10.
8. Lee C-R, Lee JH, Park KS, Jeon JH, Kim YB, Cha C-J, et al. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol. 2017; 7:483.
9. Li W, Sun G, Yu Y, Li N, Chen M, Jin R, et al. Increasing Occurrence of Antimicrobial-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Isolates in China. Clin Infect Dis 2013; 58(2):225-32.
10. Shah RK, Ni ZH, Sun XY, Wang GQ, Li F. The determination and correlation of various virulence genes, ESBL, serum bactericidal effect and biofilm formation of clinical isolated classical Klebsiella pneumoniae and hypervirulent Klebsiella pneumoniae from respiratory tract infected patients. Pol J Microb 2017; 66(4).
11. Rastegar S, Moradi M, Kalantar-Neyestanaki D, Hosseini-Nave H. Virulence factors, capsular serotypes and antimicrobial resistance of hypervirulent Klebsiella pneumoniae and classical Klebsiella pneumoniae in Southeast Iran. Infect Chemother 2019; 51.
12. Hunt JJ, Wang J-T, Callegan MC. Contribution of mucoviscosity-associated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci 2011; 52(9):6860-6.
13. Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, et al. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother 2016; 60(10):6115-20.
14. Lin Z-w, Zheng J-x, Bai B, Xu G-j, Lin F-j, Chen Z, et al. Characteristics of hypervirulent Klebsiella pneumoniae: does low expression of rmpA contribute to the absence of hypervirulence? Front microbial. 2020; 11:436.
15. Kislichkina AA, Lev AI, Komisarova EV, Fursova NK, Myakinina VP, Mukhina TN, et al. Genome sequencing and comparative analysis of three hypermucoviscous Klebsiella pneumoniae strains isolated in Russia. Pathog Dis. 2017; 75(4):ftx024.
16. Soltani E, Hasani A, Rezaee MA, Pirzadeh T, Oskouee MA, Hasani A, et al. Virulence characterization of Klebsiella pneumoniae and its relation with ESBL and AmpC beta-lactamase associated resistance. Iran J Microbiol. 2020; 12(2):98.
17. Jacob JT, Klein E, Laxminarayan R, Beldavs Z, Lynfield R, Kallen AJ, et al. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013; 62(9):165.
18. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012; 18(1):54-60.
19. Chang H-J, Hsu P-C, Yang C-C, Kuo A-J, Chia J-H, Wu T-L, et al. Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case–control study. J Microbiol Immunol Infect. 2011; 44(2):125-30.
20. Granov D, Dedeić-Ljubović A, Salimović-Bešić I. Characterization of carbapenemase-producing Klebsiella pneumoniae in clinical center university of sarajevo, Bosnia and Herzegovina. Microb Drug Resist. 2020; 26(9):1038-45.
21. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin infect dis. 2007; 44 (Supplement_2): S27-S72.
22. Berman SJ, Sieger B, Geckler RW, Farkas SA. A comparative study of meropenem and ceftazidime in the treatment of patients hospitalized with community-acquired pneumonia. Curr therap res. 1997; 58(12):903-16.
23. Hao Z, Duan J, Liu L, Shen X, Yu J, Guo Y, et al. Prevalence of Community-Acquired, Hypervirulent Klebsiella pneumoniae Isolates in Wenzhou, China. Microb Drug Resist (Larchmont, NY) 2019.
24. Xu M, Fu Y, Fang Y, Xu H, Kong H, Liu Y, et al. High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China. Infect Drug Resist. 2019; 12:641.
25. Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 2013; 4(2):107-18.
26. Aljanaby A. Virulence factors and antibiotic susceptibility patterns of multidrug resistance Klebsiella pneumoniae isolated from different clinical infections. Afr J Microbiol Res. 2016; 10:829-43.
27. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3):268-81.
28. Turton JF, Perry C, Elgohari S, Hampton CV. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol. 2010; 59(5):541-7.
29. Candan ED, Aksöz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochim Pol. 2015; 62(4):867-74.
30. Wasfi R, Elkhatib WF, Ashour HM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep. 2016; 6:38929.
31. Nei M, Li W-H. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci U S A. 1979; 76(10):5269-73.
32. Dice LR. Measures of the amount of ecologic association between species. Ecology 1945; 26(3):297-302.
33. Hirai J, Sakanashi D, Kinjo T, Haranaga S, Fujita J. The first case of community-acquired pneumonia due to capsular genotype K2-ST86 hypervirulent Klebsiella pneumoniae in Okinawa, Japan: a case report and literature review. Infect Drug Resist. 2020; 13:2237.
34. Hwang J-H, Handigund M, Hwang J-H, Cho YG, Lee J. Clinical features and risk factors associated with 30-day mortality in patients with pneumonia caused by hypervirulent Klebsiella pneumoniae (hvKP). Ann Lab Med. 2020; 40(6):481-7.
35.Yamamoto H, Iijima A, Kawamura K, Matsuzawa Y, Suzuki M, Arakawa Y. Fatal fulminant community-acquired pneumonia caused by hypervirulent Klebsiella pneumoniae K2-ST86: Case report. Medicine 2020;99(21).
36. Juan C-H, Fang S-Y, Chou C-H, Tsai T-Y, Lin Y-T. Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study. Antimicrob Resist Infect Cont. 2020; 9(1):1-8.
37. Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes?Virulence. 2017; 8(7):1111-23.
38. Luo Y, Wang Y, Ye L, Yang J. Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 2014; 20(11):O818-O24.
39. Cubero M, Grau I, Tubau F, Pallarés R, Dominguez M, Linares J, et al. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007–2013). Clin Microbiol Infect. 2016; 22(2):154-60.
40. Wu H, Li D, Zhou H, Sun Y, Shen D. Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae. Microb pathog. 2017; 104:254-62.
41. Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016; 80(3):629-61.
42. Cheng H, Chen Y, Wu C, Chang H, Lai Y, Peng H-L. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J bacterial. 2010; 192(12):3144-58.
43. Yu W-L, Ko W-C, Cheng K-C, Lee H-C, Ke D-S, Lee C-C, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin infect dis. 2006;42(10):1351-8.
44. Hao Z, Duan J, Liu L, Shen X, Yu J, Guo Y, et al. Prevalence of Community-Acquired, Hypervirulent Klebsiella pneumoniae Isolates in Wenzhou, China. Microb Drug Resist. 2020; 26(1):21-7.
45. Lin Y-T, Jeng Y-Y, Chen T-L, Fung C-P. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC infect dis. 2010; 10(1):307.
46. Shah RK, Ni ZH, Sun XY, Wang GQ, Li F. The determination and correlation of various virulence genes, ESBL, serum bactericidal effect and biofilm formation of clinical isolated classical Klebsiella pneumoniae and hypervirulent Klebsiella pneumoniae from respiratory tract infected patients. Pol J Microbiol. 2017; 66:501-8.
47. Yang Z, Liu W, Cui Q, Niu WK, Li H, Zhao XN, et al. Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-β-lactamase blaL1 in Beijing, China. Front microbiol 2014; 5:692.
48. Cao X, Xu X, Zhang Z, Shen H, Chen J, Zhang K. Molecular characterization of clinical multidrug-resistant Klebsiella pneumoniae isolates. Ann Clin Microbiol Antimicrob. 2014; 13(1):1-5.
49. Paneru TP. Surveillance of Klebsiella pneumoniae and antibiotic resistance a retrospective and comparative study through a period in Nepal. Dan J Med Biol Sci 2015: 29-36.
50. Kareem SM, Al-Kadmy IM, Kazaal SS, Mohammed Ali AN, Aziz SN, Makharita RR, et al. Detection of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae. Infect Drug Resis. 2021: 555-63.
51. Pomakova D, Hsiao C, Beanan J, Olson R, MacDonald U, Keynan Y, et al. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur j Clin Microbiol Infect Dis. 2012; 31(6):981-9.
52. Ma Y, Bao C, Liu J, Hao X, Cao J, Ye L, et al. Microbiological characterisation of Klebsiella pneumoniae isolates causing bloodstream infections from five tertiary hospitals in Beijing, China. J Glob Antimicrob Resist. 2018; 12:162-6.
53. Decré D, Verdet C, Emirian A, Le Gourrierec T, Petit J-C, Offenstadt G, et al. Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J clin microbial. 2011; 49(8):3012-4.
54. Pan Y-J, Fang H-C, Yang H-C, Lin T-L, Hsieh P-F, Tsai F-C, et al. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J clin microbial. 2008; 46(7):2231-40.
55. Chung DR, Park MH, Kim SH, Ko KS, Kang C-I, Peck KR, et al. Prevalence and molecular characterization of serotype K1 Klebsiella pneumoniae strains from various clinical specimen sources in 11 Asian countries. J Infect. 2012;64(6):622-5.
56. Struve C, Roe C, Stegger M, Stahlhut S, Hansen D, Engelthaler D, et al. Mapping the evolution of hypervirulent Klebsiella pneumoniae mBio. 6: e00630. 2015.
57. Fang C-T, Lai S-Y, Yi W-C, Hsueh P-R, Liu K-L, Chang S-C. Klebsiella pneumoniae Genotype K1: An Emerging Pathogen That Causes Septic Ocular or Central Nervous System Complications from Pyogenic Liver Abscess. Clin Infect Dis. 2007; 45(3):284-93.
58. Yeh K-M, Chiu S-K, Lin C-L, Huang L-Y, Tsai Y-K, Chang J-C, et al. Surface antigens contribute differently to the pathophysiological features in serotype K1 and K2 Klebsiella pneumoniae strains isolated from liver abscesses. Gut Pathog. 2016; 8(1):4.
59. Candan ED, Aksöz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochim Pol. 2015; 62(4).
60. Liu YM, Li BB, Zhang YY, Zhang W, Shen H, Li H, et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother. 2014;58(9):5379-85.
61. Jung S, Chae H, Park Y, Yu J, Kim S, Lee H, et al. Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea. Epidemiol Infect. 2013; 141(2):334-40.
62. Fang C-T, Chuang Y-P, Shun C-T, Chang S-C, Wang J-T. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med. 2004; 199(5):697-705.
63. Feizabadi MM, Raji N, Delfani S. Identification of Klebsiella pneumoniae K1 and K2 capsular types by PCR and quellung test. Jundishapur J Microbiol 2013; 6(9).
64. Fu L, Huang M, Zhang X, Yang X, Liu Y, Zhang L, et al. Frequency of virulence factors in high biofilm formation blaKPC-2 producing Klebsiella pneumoniae strains from hospitals. Microb pathog. 2018; 116:168-72.
65. Siu LK, Yeh K-M, Lin J-C, Fung C-P, Chang F-Y. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012; 12(11):881-7.
66. Rivero A, Gomez E, Alland D, Huang DB, Chiang T. K2 serotype Klebsiella pneumoniae causing a liver abscess associated with infective endocarditis. J Clin Microbiol 2010; 48(2):639-41.
67. Hasani A, Soltani E, Rezaee MA, Pirzadeh T, Oskouee MA, Hasani A, et al. Serotyping of Klebsiella pneumoniae and its relation with capsule-associated virulence genes, antimicrobial resistance pattern, and clinical infections: a descriptive study in medical practice. Infect Drug Resist. 2020; 13:1971.
68. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathologie Biologie. 2013;61(5):209-16.
69. Cammarota M, Bevilaqua LR, Kerr D, Medina JH, Izquierdo I. Inhibition of mRNA and protein synthesis in the CA1 region of the dorsal hippocampus blocks reinstallment of an extinguished conditioned fear response. J Neurosci 2003;23(3):737-41.
70. Regué M, Hita B, Piqué N, Izquierdo L, Merino S, Fresno S, et al. A gene, uge, is essential for Klebsiella pneumoniae virulence. Infect Immun. 2004; 72(1):54-61.
71. Lev AI, Astashkin EI, Kislichkina AA, Solovieva EV, Kombarova TI, Korobova OV, et al. Comparative analysis of Klebsiella pneumoniae strains isolated in 2012–2016 that differ by antibiotic resistance genes and virulence genes profiles. Pathog Glob Health. 2018; 112(3):142-51.
72. May T, Okabe S. Enterobactin is required for biofilm development in reduced‐genome Escherichia coli. Environ Microbiol. 2011; 13(12):3149-62.
73. Aljanaby AAJ, Alhasani AHA. Virulence factors and antibiotic susceptibility patterns of multidrug resistance Klebsiella pneumoniae isolated from different clinical infections. Afr J Microbiol Res 2016; 10(22):829-43.
74. Aher T, Roy A, Kumar P. Molecular detection of virulence genes associated with pathogenicity of Klebsiella spp. isolated from the respiratory tract of apparently healthy as well as sick goats. Israel J Vet Med. 2012; 67(4):249-52.
75. Victor LY, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, Von Gottberg A, et al. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis. 2007; 13(7):986.
76. Kim YJ, Kim SI, Kim YR, Wie SH, Lee HK, Kim S-Y, et al. Virulence factors and clinical patterns of hypermucoviscous Klebsiella pneumoniae isolated from urine. Infect Dis 2017; 49(3):178-84.
77. Zheng J-x, Lin Z-w, Chen C, Chen Z, Lin F-j, Wu Y, et al. Biofilm formation in Klebsiella pneumoniae bacteremia strains was found to be associated with CC23 and the presence of wcaG. Front Cell Infect Microbiol. 2018; 8:21.
78. Guo Y, Wang S, Zhan L, Jin Y, Duan J, Hao Z, et al. Microbiological and clinical characteristics of hypermucoviscous Klebsiella pneumoniae isolates associated with invasive infections in China. FrontCell Infect Microbiol. 2017; 7:24.
79. Ramazanzadeh R, Zamani S, Zamani S. Genetic diversity in clinical isolates of Escherichia coli by enterobacterial repetitive intergenic consensus (ERIC)–PCR technique in Sanandaj hospitals. Iran j Microbiol. 2013; 5(2):126.
80. Seifi K, Kazemian H, Heidari H, Rezagholizadeh F, Saee Y, Shirvani F, et al. Evaluation of biofilm formation among Klebsiella pneumoniae isolates and molecular characterization by ERIC-PCR. Jundishapur J Microbiol. 2016; 9(1).
81. Yan J-J, Hsueh P-R, Lu J-J, Chang F-Y, Shyr J-M, Wan J-H, et al. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob AgentsChemother 2006; 50(5):1861-4.
82. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob AgentsChemother 2003; 47(12):3724-32.
83. Lagha N, Abdelouahid DE, Hassaine H, Robin F, ederic, Bonnet R. First characterization of CTX-M-15 and DHA-1-lactamases among clinical isolates of Klebsiella pneumoniae in Laghouat Hospital, Algeria. Afr J Microbiol Res 2014; 8(11):1221-7.
84. Mehr VP, Shokoohizadeh L, Mirzaee M, Savari M. Molecular Typing of Klebsiella pneumoniae Isolates by Enterobacterial Repetitive Intergenic Consensus (ERIC)–PCR. Infect Epidemiol Microbiol. 2017;3(4):112-6.
85. Mahmoudi F, Momtaz H. Detection of Capsular Types in Klebsiella Pneumoniae Strains isolated from Bovine Mastitis. NavidNo. 2019;22(71):11-8.
86. Paknejad Z, Momtaz H, Tajbakhsh E. Determination of antibiotic resistance pattern in different serotypes of Klebsiella pneumoniae strains isolated from hospital infections in Zarinshahr. Sci Res Appl Biol 2018; 8(29):21-30.
87. Tang HL, Chiang MK, Liou WJ, Chen YT, Peng HL, Chiou CS, et al. Correlation between Klebsiella pneumoniae carrying pLVPK-derived loci and abscess formation. Eur J Clin Microbiol Infect Dis. 2010; 29(6):689-98.
88. Turton J, Perry C, Elgohari S, Hampton C. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol 2010;59:541-7.
89. Naga IS. Detection of Biofilm and Siderophore Encoding Genes Implicated in the Pathogenesis of Klebsiella pneumoniae Isolated from Different Clinical Specimens. Egypt J Med Microbiol. 2021; 30(1):101-8.
90. Wu Y, Yang Y, Dang H, Xiao H, Huang W, Jia Z, et al. Molecular identification of Klebsiella pneumoniae and expression of immune genes in infected spotted gar Lepisosteus oculatus. Fish Shellfish Immunol. 2021; 119:220-30.
91. Fertas-Aissani R, Messai Y, Alouache S, Bakour R. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol Biol (Paris). 2012; 61.
92. Lin J-C, Koh TH, Lee N, Fung C-P, Chang F-Y, Tsai Y-K, et al. Genotypes and virulence in serotype K2 Klebsiella pneumoniae from liver abscess and non-infectious carriers in Hong Kong, Singapore and Taiwan. Gut Pathog. 2014; 6-21.
93. Chen Z, Liu M, Cui Y, Wang L, Zhang Y, Qiu J, et al. A novel PCR-based genotyping scheme for clinical Klebsiella pneumoniae. Future microbiol. 2014; 9(1):21-32.
94. KUŞ H, ARSLAN U, DAĞI HT, FINDIK D. Hastane Enfeksiyonu Etkeni Klebsiella pneumoniae İzolatlarında Çeşitli Virülans Faktörlerinin Araştırılması. Mikrobiyol Bul. 2017; 51(4):329-39.